Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jacobs Holding is a Swiss private investment and holding company founded in 1994 by Klaus J. Jacobs. It is a long-term investment firm rather than an operating biotech, pharma, or healthcare product company, with investments spanning consumer, education, services, and healthcare-related businesses. In healthcare, its exposure has primarily been through ownership of provider and services assets such as Colosseum Dental Group, North American Dental Group, Helios Global Group, Stingray Healthcare, MedEuropa, and Sanoptis rather than through drug discovery or therapeutic development. In June 2025, Jacobs Holding and Telemos Capital combined to form Jacobs Capital. The firm is ultimately associated with the Jacobs family and the Jacobs Foundation and is focused on control or co-control investments in market-leading businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jacobs Holding.